Liver Cirrhosis Recruiting Phase 1 / 2 Trials for Erlotinib (DB00530)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02273362Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the LiverPrevention